​

Cellectar Biosciences Ownership | Who Owns Cellectar Biosciences?

OverviewForecastFinancialsChartTranscripts

Cellectar Biosciences Ownership Summary

Cellectar Biosciences is owned by 0.09% institutional investors, 1.71% insiders, and 98.20% retail investors. Adar1 capital management is the largest institutional shareholder, holding 0.09% of CLRB shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.33% of its assets in Cellectar Biosciences shares.

CLRB Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCellectar Biosciences0.09%1.71%98.20%
SectorHealthcare Stocks 278.45%10.60%-189.04%
IndustryBiotech Stocks 63.84%10.66%25.50%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Adar1 capital management40.23K0.09%$12.68K
Two sigma securities---
Altium capital management lp---
Bfsg---
Bnp paribas arbitrage, snc---
Citigroup---
Enrich financial partners---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Adar1 capital management40.23K0.00%$12.68K
Two sigma securities---
Altium capital management lp---
Bfsg---
Bnp paribas arbitrage, snc---
Citigroup---
Enrich financial partners---

Top Buyers

HolderShares% AssetsChange
Enrich financial partners---102.00
Citigroup---660.00
Bfsg---1.00K
Bnp paribas arbitrage, snc---16.82K
Two sigma securities---51.95K

Top Sellers

HolderShares% AssetsChange
Adar1 capital management40.23K0.00%-545.03K
Altium capital management lp---215.00K
Two sigma securities---51.95K
Bnp paribas arbitrage, snc---16.82K
Bfsg---1.00K

Sold Out

HolderChange
Enrich financial partners-102.00
Citigroup-660.00
Bfsg-1.00K
Bnp paribas arbitrage, snc-16.82K
Two sigma securities-51.95K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20251-96.88%40,228-99.21%-0.05%--100.00%1-83.33%
Dec 31, 202432-13.51%5,096,844-63.61%131.10%1721.43%6-33.33%
Sep 30, 202437-7.50%14,004,95420.80%353.40%14-36.36%912.50%
Jun 30, 202440-21.57%11,593,73326.98%323.34%22-38.89%860.00%
Mar 31, 20245196.15%9,130,4256.12%311.46%36140.00%5-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.07M2.33%-
Vanguard Total Stock Mkt Idx Inv1.07M2.33%-
Vanguard Institutional Extnd Mkt Idx Tr568.75K1.23%-
Fidelity Extended Market Index229.76K0.50%-2.20K
BlackRock Extended Equity Market K72.26K0.20%-31.00
iShares Micro-Cap ETF73.44K0.16%-
Extended Equity Market Fund K71.50K0.16%219.00
Fidelity Total Market Index61.94K0.13%-
Spartan Extended Market Index Pool F58.87K0.13%2.20K
Spartan Extended Market Index Pool E56.68K0.12%27.44K

Recent Insider Transactions

DateNameRoleActivityValue
Jul 02, 2025CARUSO JAMES V Chief Executive OfficerBuy$52.50K
Jul 02, 2025CARUSO JAMES V Chief Executive OfficerBuy$49.90K
Jul 02, 2025Longcor Jarrod Chief Operating OfficerBuy$49.90K
Jul 02, 2025Longcor Jarrod Chief Operating OfficerBuy$52.50K
Jul 02, 2025Kolean Chad J Chief Financial OfficerBuy$24.95K

Insider Transactions Trends

DateBuySell
2025 Q36-
2025 Q11-
2024 Q2--
2023 Q4--
2023 Q2--

CLRB Ownership FAQ

Who Owns Cellectar Biosciences?

Cellectar Biosciences shareholders are primarily institutional investors at 0.09%, followed by 1.71% insiders and 98.20% retail investors. The average institutional ownership in Cellectar Biosciences's industry, Biotech Stocks , is 63.84%, which Cellectar Biosciences falls below.

Who owns the most shares of Cellectar Biosciences?

Cellectar Biosciences’s largest shareholders are Adar1 capital management (40.23K shares, 0.09%), Two sigma securities (0 shares, 0%), and Altium capital management lp (0 shares, 0%). Together, they hold 0.09% of Cellectar Biosciences’s total shares outstanding.

Does Blackrock own Cellectar Biosciences?

BlackRock is not among the top 10 institutional shareholders of Cellectar Biosciences.

Who is Cellectar Biosciences’s biggest shareholder by percentage of total assets invested?

Adar1 capital management is Cellectar Biosciences’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 40.23K Cellectar Biosciences shares, valued at 12.68K$.

Who is the top mutual fund holder of Cellectar Biosciences shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Cellectar Biosciences shares, with 2.33% of its total shares outstanding invested in 1.07M Cellectar Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools